Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Canopy FGF signaling regulator 4 (CNPY4) is a protein encoded by the CNPY4 gene in humans and belongs to the family of canopy fibroblast growth factor (FGF) signaling regulators. CNPY4 is predicted to enable signaling receptor binding activity and functions as a positive regulator of protein localization to the plasma membrane. The umbrella group of canopy FGF signaling regulators is noted for their roles in modulating FGF signaling pathways, but specific disease associations or therapeutic interactions for CNPY4 itself are minimally reported in current literature and genetic databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Canopy FGF signaling regulator 4 (CNPY4).